Keywords: پالونوستررون; Buccal delivery; Drug release; Eudragit; Proloc; Palonosetron; Permeation;
مقالات ISI پالونوستررون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پالونوستررون; Anti-emesis; Aprepitant; Chemotherapy; Cisplatin; Palonosetron
Keywords: پالونوستررون; anti-emetics; palonosetron; postoperative nausea and vomiting;
Keywords: پالونوستررون; palonosetron; prophylaxis; PONV; 5-HT3RA; meta-analysis
Influence of skin permeation enhancers on the transdermal delivery of palonosetron: An in vitro evaluation
Keywords: پالونوستررون; Palonosetron; Transdermal; Adhesive; Enhancers; Release;
O efeito de palonosetron sobre o movimento de retração induzido por rocurônio
Keywords: پالونوستررون; Palonosetron; Rocurônio; Injeção; Dor; Reflexo de retirada; Palonosetron; Rocuronium; Injection; Pain; Withdrawal movement;
Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials
Keywords: پالونوستررون; NEPA; CINV; Breast cancer; Antiemetic; Netupitant; Palonosetron;
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients
Keywords: پالونوستررون; Neurokinin-1 receptor antagonist; Netupitant; 5-Hydroxytryptamine receptor antagonist; Palonosetron; NEPA; CINV; Multiple chemotherapy cycles; Older patients; Moderately emetogenic chemotherapy; Highly emetogenic chemotherapy;
Ca2 + signaling and emesis: Recent progress and new perspectives
Keywords: پالونوستررون; Cancer; Cisplatin; Vomiting; Emesis; Antiemesis; Ca2Â +; Â L-type Ca2Â + channel; Palonosetron; Netupitant; CB1 receptor;
The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva)
Keywords: پالونوستررون; Cisplatin; Emesis; Pranlukast; Palonosetron; Tropisetron; Netupitant; Antiemetic;
Effectiveness of palonosetron in prevention of CHOP induced nausea and vomiting in patients with malignant lymphoma
Keywords: پالونوستررون; CHOP; CINV; Malignant lymphoma; Palonosetron;
Synthesis and evaluation of (S)-[18F]fesetron in the rat brain as a potential PET imaging agent for serotonin 5-HT3 receptors
Keywords: پالونوستررون; Fesetron; Serotonin 5-HT3 receptors; PET; Autoradiography; Palonosetron; Zacopride; Cancer chemotherapy;
Development and validation of a rapid LC–MS/MS method for simultaneous determination of netupitant and palonosetron in human plasma and its application to a pharmacokinetic study
Keywords: پالونوستررون; Netupitant; Palonosetron; LC–MS/MS; Human plasma; Pharmacokinetics
Drug in adhesive patch of palonosetron: Effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation
Keywords: پالونوستررون; Palonosetron; Drug-in-adhesive patch; Drug-PSA interaction; Pharmacokinetic; In vitro-in vivo correlation;
Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia
Keywords: پالونوستررون; anti-emetics; electrocardiography; palonosetron; postoperative nausea and vomiting; serotonin 5-HT3 receptor antagonists; sevoflurane;
Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT3 receptor antagonist palonosetron in the least shrew (Cryptotis parva)
Keywords: پالونوستررون; Least shrew; Emesis; L-type calcium channel; 5-HT3 receptor; D2 receptor; NK1 receptor; M1 receptor; FPL 64176; Nifedipine; Palonosetron; 2-Me-5-HT; Apomorphine; Quinpirole; McN-A-343; Cisplatin
Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
Keywords: پالونوستررون; Ondansetron; Granisetron; Dolasetron; Tropisetron; Palonosetron; Aprepitant; Netupitant; 5-HT3 receptor; NK1 receptor
Long-Acting Serotonin Antagonist (Palonosetron) and the NK-1 Receptor Antagonists
Keywords: پالونوستررون; Postoperative; Postdischarge; Nausea; Vomiting; Palonosetron; Aprepitant; Casopitant; Rolapitant;
Exploring a potential palonosetron allosteric binding site in the 5-HT3 receptor
Keywords: پالونوستررون; 5-HT; 5-hydroxytryptamine (serotonin); EC50; concentration of agonist required for half-maximal response; HEK; human embryonic kidney; IC50; concentration of antagonist required for half-maximal inhibition; Kd; affinity constant; Serotonin receptor; Allos
Postoperative nausea and vomiting prophylaxis: The efficacy of a novel antiemetic drug (palonosetron) combined with dexamethasone
Keywords: پالونوستررون; Postoperative nausea and vomiting; Antiemetics; Dexamethasone; Metoclopramide; Palonosetron
Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects
Keywords: پالونوستررون; Substance P; Netupitant; Palonosetron; Chemotherapy induced nausea and vomiting;
Determination of palonosetron in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
Keywords: پالونوستررون; Palonosetron; UPLC–MS/MS; Human plasma; Bioanalysis; Pharmacokinetics
Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting
Keywords: پالونوستررون; Palonosetron; Ondansetron; Granisetron; Netupitant; 5-HT3 receptor; NK1 receptor;
Liquid chromatography–electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of palonosetron in human plasma and urine: Application to a pharmacokinetic study
Keywords: پالونوستررون; Palonosetron; LC–MS/MS; Pharmacokinetics
The role of second-generation 5-HT3 receptor antagonists in managing chemotherapy-induced nausea and vomiting in hematological malignancies
Keywords: پالونوستررون; Chemotherapy-induced nausea and vomiting; Antiemetics; 5HT3 receptor antagonists; Palonosetron; Stem cell transplantation
Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
Keywords: پالونوستررون; 5-HT3 receptor; Palonosetron; Granisetron; Ondansetron; Receptor internalization
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: C
Keywords: پالونوستررون; Palonosetron; 5HT3 receptor antagonist; Antiemetic; Chemotherapy-induced nausea and vomiting (acute-, delayed-, and overall-phase); Highly and moderately emetogenic chemotherapy; Elderly and non-elderly patients
Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients: A phase II study of the Gruppo Oncologico dell' Italia Meridionale (GOIM)
Keywords: پالونوستررون; Supportive care; Antiemetic drugs; Palonosetron;
Palonosetron Hydrochloride Is an Effective and Safe Option to Prevent Chemotherapy-induced Nausea and Vomiting in Children
Keywords: پالونوستررون; Pediatric cancer; Palonosetron; Antiemetic treatment
Determination of palonosetron in human plasma by liquid chromatography–electrospray ionization-mass spectrometry
Keywords: پالونوستررون; Palonosetron; HPLC–ESI-MS; Pharmacokinetics